Position in APGE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$149,472,427
+$73,646,116 QoQ
Shares Held
1,126,139
+25.0% QoQ
Ownership
1.49%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#19
of 285 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Derivatives in APGE
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$67,541
PutShares
1,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. APGE ranks #16 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in APGE
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $149,472,427 | 1,126,139 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $75,826,311 | 900,871 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $59,908,095 | 793,695 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $67,541 | 1,700 | Put | Defined | 2026-02-03 | |
| 2025-09-30 | $15,650,121 | 393,912 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $73,831 | 1,700 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $22,105,303 | 508,987 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,910,875 | 425,880 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $63,512 | 1,700 | Put | Defined | 2025-05-15 | |
| 2024-12-31 | $4,780,960 | 105,540 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $17,590,984 | 299,472 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,755,028 | 349,556 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $26,365,897 | 396,778 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $13,668,499 | 489,209 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $438,140 | 20,570 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||